901 The impact of frozen biopsy of bladder tumor bed during transurethral resection: A randomized prospective trial

2014 ◽  
Vol 13 (1) ◽  
pp. e901-e901a
Author(s):  
Juveniz J.A.Q.J. Queiroz ◽  
Sant Anna A.C.S. Crippa ◽  
Dalloglio M.F.D. Francisco ◽  
Nesrallah A.J.N. João ◽  
Chade D.C.C. Cezar ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Prospective Trial ◽  
Tumor Bed ◽  
Randomized Prospective Trial ◽  
The Impact

MP65-10 THE IMPACT OF FROZEN BIOPSY OF BLADDER TUMOR BED DURING TRANSURETHRAL RESECTION: A RANDOMIZED PROSPECTIVE TRIAL

2014 ◽  
Vol 191 (4S) ◽  
Author(s):  
João Alexandre Queiroz Juveniz ◽  
Alexandre Crippa Sant Anna ◽  
Marcos Francisco ◽  
Dall Oglio ◽  
Adriano João Nesrallah ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Prospective Trial ◽  
Tumor Bed ◽  
Randomized Prospective Trial ◽  
The Impact

Value of Immediate Second Resection of the Tumor Bed to Improve the Effectiveness of Transurethral Resection of Bladder Tumor

2012 ◽  
Vol 26 (8) ◽  
pp. 1059-1064 ◽  
Author(s):  
Wansuk Kim ◽  
Cheryn Song ◽  
Sejun Park ◽  
Jongwon Kim ◽  
Jinsung Park ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Tumor Bed ◽  
Second Resection

Thulium Laser versus Standard Transurethral Resection of the Prostate: A Randomized Prospective Trial

2008 ◽  
Vol 53 (2) ◽  
pp. 382-390 ◽  
Author(s):  
Shu-Jie Xia ◽  
Jian Zhuo ◽  
Xiao-Wen Sun ◽  
Bang-Min Han ◽  
Yi Shao ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Prospective Trial ◽  
Thulium Laser ◽  
Randomized Prospective Trial

1891 VALUE OF FROZEN BIOPSY OF THE TUMOR BED IN IMPROVING THE EFFECTIVENESS OF TRANSURETHRAL RESECTION OF BLADDER TUMOR

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Wansuk Kim ◽  
Myung-Chan Park ◽  
Jongwon Kim ◽  
Sungwoo Hong ◽  
Seong Cheol Kim ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Tumor Bed

1881 IMPACT OF FROZEN BIOPSY OF BLADDER TUMOR BED DURING TRANSURETHRAL RESECTION ON RESIDUAL TUMOR AND UPSTAGING AT RETUR

2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
JOÃO ALEXANDRE QUEIROZ JUVENIZ ◽  
ADRIANO JOÃO NESRALLAH ◽  
ALEXANDRE CRIPPA SANT'ANNA ◽  
CARLOS HIROKATSU WATANABE SILVA ◽  
CLAUDIO BOVOLENTA MURTA ◽  
...  
Keyword(s):  
Transurethral Resection ◽  
Bladder Tumor ◽  
Residual Tumor ◽  
Tumor Bed

scholarly journals GCT-33. A PHASE 2 TRIAL OF RESPONSE-BASED RADIATION THERAPY FOR PATIENTS WITH LOCALIZED CENTRAL NERVOUS SYSTEM GERM CELL TUMORS: A CHILDREN’S ONCOLOGY GROUP (COG) STUDY. IMPACT OF RAPID CENTRAL RADIOTHERAPY REVIEW ON RADIOTHERAPY QUALITY AND PATTERN OF FAILURE FOR NON-GERMINOMATOUS GERM CELL TUMORS

2020 ◽  
Vol 22 (Supplement_3) ◽  
pp. iii334-iii334
Author(s):  
Erin S Murphy ◽  
Girish Dhall ◽  
Jason Fangusaro ◽  
Ute Bartels ◽  
Maryam Fouladi ◽  
...  
Keyword(s):  
Germ Cell ◽  
Prospective Trial ◽  
Germ Cell Tumors ◽  
Complete Response ◽  
Leptomeningeal Disease ◽  
Pattern Of Failure ◽  
Tumor Bed ◽  
Phase 2 Trial ◽  
Local Progression ◽  
The Impact

Abstract BACKGROUND COG ACNS 1123 tested reduced radiotherapy (RT) for non-metastatic, non-germinomatous germ cell tumor (NGGCT) patients. The impact of central review on quality of RT and pattern of failure for NGGCT patients is evaluated. METHODS Patients who achieved a complete response (CR) or partial response (PR) to induction chemotherapy were eligible for reduced dose and field RT of 30.6 Gy whole ventricular field (WVI) and 54 Gy tumor-bed total dose. An online contouring atlas was available. Within three days of RT start, WVI plans were submitted for rapid central review. Within one week of RT completion, the complete RT record was submitted. Brain and spine MRIs of relapsed patients were centrally reviewed. RESULTS Between 5/2012–9/2016, 107 eligible patients were accrued and 70 met reduced RT criteria. Rapid RT review was performed for 49 (70%) of 70 patients. Forty-four (89.8%) required no modification. All modifications were completed and plans became compliant. Final central review was performed for 66 evaluable patients: 62 (94%) were per protocol; there were 2 major (1 dose and 1 target) and 2 minor deviations. Eight patients progressed; none had deviations. Median time to progression was 3.54 months (range: 1.7–19.1) from RT start. All failures had a spine component; two also had cranial component: one local progression (within the RT boost volume) and one leptomeningeal disease. CONCLUSION Providing an online contouring atlas and performing a rapid central review lead to high quality radiotherapy on this prospective trial. The deviations did not contribute to the pattern of failure.

Sign in / Sign up

Export Citation Format

Share Document